)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Praxis Precision Medicines
Praxis Precision Medicines (PRAX) investor relations material
Praxis Precision Medicines Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary30 Apr, 2026
Voting matters and shareholder proposals
Election of three Class III Directors to serve until the 2029 Annual Meeting, with nominees Gregory Norden, Marcio Souza, and William Young recommended for election.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory (non-binding) vote to approve the compensation of named executive officers as disclosed in the proxy statement, including Compensation Discussion and Analysis and related tables.
Authorization to transact any other business that may properly come before the meeting or any adjournment or postponement.
Board of directors and corporate governance
Board recommends the election of all three Class III Director nominees for terms expiring at the 2029 Annual Meeting.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the compensation of named executive officers as detailed in the proxy statement.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Praxis Precision Medicines
- 2026 proxy details director elections, auditor ratification, and strong pay-for-performance alignment.PRAX
Proxy filing30 Apr 2026 - Ulyxa NDA advances with robust launch plans and pipeline catalysts expected in 2024.PRAXTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Two NDA filings, strong clinical data, and $1.5B cash position set up multiple 2026 launches.PRAXQ4 202519 Feb 2026
- Late-stage CNS pipeline targets >$20B revenue with strong efficacy, safety, and IP protection.PRAXCorporate presentation19 Feb 2026
- Two NDAs set for mid-February aim to address major CNS markets with strong launch plans.PRAXGuggenheim Securities Emerging Outlook: Biotech Summit 202611 Feb 2026
- Pivotal epilepsy programs show robust efficacy, rapid progress, and major commercial potential.PRAXH.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026
- Late-stage trials advance for essential tremor and epilepsy, with strong pipeline and disciplined growth.PRAXJefferies Global Healthcare Conference1 Feb 2026
- Multiple late-stage trials advance with $433.8M cash and key data readouts expected in 2024-2025.PRAXQ2 20241 Feb 2026
- Relutrigine achieved 46% seizure reduction and over 30% seizure freedom in DEE patients.PRAXStudy Result22 Jan 2026
Next Praxis Precision Medicines earnings date
Q1 20268 May, 2026
Praxis Precision Medicines
Next Praxis Precision Medicines earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage